Humacyte's total assets for Q3 2025 were $91.51M, a decrease of -34.07% from the previous quarter. HUMA total liabilities were $96.26M for the fiscal quarter, a -28.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.